Parkinson Disease (immunology) < Parkinson Disease (metabolism) < Parkinson Disease (microbiology)

Facettes :

List of bibliographic references indexed by Parkinson Disease (metabolism)

Number of relevant bibliographic references: 290.
[40-60] [0 - 20][0 - 50][60-80]

Ident.	Authors (with country if any)	Title
000764 (2015)	Lorraine V. Kalia [Canada] ; Suneil K. Kalia [Canada] ; Anthony E. Lang [Canada]	Disease-modifying strategies for Parkinson's disease.
000786 (2015)	Nicolas Morin [Canada] ; Marc Morissette [Canada] ; Laurent Grégoire [Canada] ; Alex Rajput [Canada] ; Ali H. Rajput [Canada] ; Thérèse Di Paolo [Canada]	Contribution of brain serotonin subtype 1B receptors in levodopa-induced motor complications.
000789 (2015)	Christina Poetschke [Allemagne] ; Elena Dragicevic [Allemagne] ; Johanna Duda [Allemagne] ; Julia Benkert [Allemagne] ; Antonios Dougalis [Allemagne] ; Roberta Dezio [Allemagne] ; Terrance P. Snutch [Canada] ; Joerg Striessnig [Autriche] ; Birgit Liss [Allemagne]	Compensatory T-type Ca2+ channel activity alters D2-autoreceptor responses of Substantia nigra dopamine neurons from Cav1.3 L-type Ca2+ channel KO mice
000798 (2015)	Mattia Volta [Canada] ; Stefano Cataldi [Canada] ; Dayne Beccano-Kelly [Canada] ; Lise Munsie [Canada] ; Igor Tatarnikov [Canada] ; Patrick Chou [Canada] ; Sabrina Bergeron [Canada] ; Emma Mitchell [Canada] ; Roscoe Lim [Canada] ; Jaskaran Khinda [Canada] ; Alejandro Lloret [États-Unis] ; C Frank Bennett [États-Unis] ; Carmela Paradiso [Italie] ; Michele Morari [Italie] ; Matthew J. Farrer [Canada] ; Austen J. Milnerwood [Canada]	Chronic and acute LRRK2 silencing has no long-term behavioral effects, whereas wild-type and mutant LRRK2 overexpression induce motor and cognitive deficits and altered regulation of dopamine release.
000802 (2015)	Hélène Doucet-Beaupré [Canada] ; Siew-Lan Ang [Royaume-Uni] ; Martin Lévesque [Canada]	Cell fate determination, neuronal maintenance and disease state: The emerging role of transcription factors Lmx1a and Lmx1b.
000837 (2015)	Eric Béliveau [Canada] ; Cyntia Tremblay [Canada] ; Émilie Aubry-Lafontaine [Canada] ; Sarah Paris-Robidas [Canada] ; Charlotte Delay [Canada] ; Chris Robinson [Canada] ; Les Ferguson [Canada] ; Ali H. Rajput [Canada] ; Alex Rajput [Canada] ; Frédéric Calon [Canada]	Accumulation of amyloid-β in the cerebellar cortex of essential tremor patients.
000851 (2015)	Beryl Luk [Canada] ; Mohinuddin Mohammed [Canada] ; Fang Liu [Canada] ; Frank J. S. Lee [Canada]	A Physical Interaction between the Dopamine Transporter and DJ-1 Facilitates Increased Dopamine Reuptake
000853 (2015)	Hyman M. Schipper [Canada] ; Wei Song	A Heme Oxygenase-1 Transducer Model of Degenerative and Developmental Brain Disorders
000881 (2014)	Ke Wang [Canada] ; Shengchun Liu ; Juelu Wang ; Yili Wu ; Fang Cai ; Weihong Song	Transcriptional regulation of human USP24 gene expression by NF-kappa B.
000936 (2014)	Leigh Christopher [Canada] ; Sarah Duff-Canning [Canada] ; Yuko Koshimori [Canada] ; Barbara Segura [Canada, Espagne] ; Isabelle Boileau [Canada] ; Robert Chen [Canada] ; Anthony E. Lang [Canada] ; Sylvain Houle [Canada] ; Pablo Rusjan [Canada] ; Antonio P. Strafella [Canada]	Salience Network and Parahippocampal Dopamine Dysfunction in Memory-Impaired Parkinson Disease
000951 (2014)	Rajesh Pahwa [États-Unis] ; Kelly E. Lyons [États-Unis] ; Robert A. Hauser [États-Unis] ; Stanley Fahn [États-Unis] ; Joseph Jankovic [États-Unis] ; Emmanuelle Pourcher [Canada] ; Ann Hsu [États-Unis] ; Martin O'Connell [États-Unis] ; Sherron Kell [États-Unis] ; Suneel Gupta [États-Unis]	Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease.
000967 (2014)	Lynda Peterson [États-Unis] ; Kathleen P. Ismond [Canada] ; Elisha Chapman [Canada] ; Patrick Flood [Canada, États-Unis]	Potential Benefits of Therapeutic Use of β2-Adrenergic Receptor Agonists in Neuroprotection and Parkinsonμs Disease
000983 (2014)	Gian-Luca Mclelland [Canada] ; Vincent Soubannier [Canada] ; Carol X. Chen [Canada] ; Heidi M. Mcbride [Canada] ; Edward A. Fon [Canada]	Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control
000A10 (2014)	Penelope J. Hallett [États-Unis] ; Oliver Cooper [États-Unis] ; Damaso Sadi [Canada] ; Harold Robertson [Canada] ; Ivar Mendez [Canada] ; Ole Isacson [États-Unis]	Long-term dopamine transporter expression and normal cellular distribution of mitochondria in dopaminergic neuron transplants in Parkinson’s disease patients
000A29 (2014)	Nicolas Morin [Canada] ; Thérèse Di Paolo [Canada]	Interaction of adenosine receptors with other receptors from therapeutic perspective in Parkinson's disease.
000A37 (2014)	Plamena R. Angelova [Canada] ; Bikram Keshari Agrawalla ; Pia A. Elustondo ; Jacob Gordon ; Toshikazu Shiba ; Andrey Y. Abramov ; Young-Tae Chang ; Evgeny V. Pavlov	In situ investigation of mammalian inorganic polyphosphate localization using novel selective fluorescent probes JC-D7 and JC-D8.
000A54 (2014)	Sarah Christine Lidstone [Canada]	Great expectations: the placebo effect in Parkinson's disease.
000B12 (2014)	Anne-Marie Arel-Dubeau [Canada] ; Fanny Longpré [Canada] ; Julie Bournival [Canada] ; Cindy Tremblay [Canada] ; Julie Demers-Lamarche [Canada] ; Pavlina Haskova [Canada, République tchèque] ; Everaldo Attard [Malte] ; Marc Germain [Canada] ; Maria-Grazia Martinoli [Canada]	Cucurbitacin E Has Neuroprotective Properties and Autophagic Modulating Activities on Dopaminergic Neurons
000B53 (2014)	Naomi P. Visanji [Canada] ; Connie Marras ; Lili-Naz Hazrati ; Louis W C. Liu ; Anthony E. Lang	Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker.
000B69 (2014)	Mariya V. Cherkasova ; A. Jon Stoessl	A brain network response to sham surgery
000B96 (2014)	Kenneth Marek [États-Unis] ; John Seibyl [États-Unis] ; Shirley Eberly [États-Unis] ; David Oakes [États-Unis] ; Ira Shoulson [États-Unis] ; Anthony E. Lang [Canada] ; Chris Hyson [Canada] ; Danna Jennings [États-Unis]	Longitudinal follow-up of SWEDD subjects in the PRECEPT Study

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Parkinson Disease (metabolism)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Parkinson Disease (metabolism)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Parkinson Disease (metabolism)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022